Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its ...

Regeneron will acquire 23andMe’s core assets for $256 million, ensuring customer data privacy and continuing the mission of ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

Some public libraries have yearbooks from the schools that used to serve their towns. The Hoyt Memorial Library in Kingston ...

In this week’s edition of The Prototype, we look at why you still can’t rely on chatbots, a new battery chemistry that could ...

For a decade or so, gold prices have been at a big premium to platinum. But with platinum demand strong and supply down, ...

Regeneron (REGN) announced initial results from two cohorts of the Phase 1b LINKER-MM2 trial evaluating linvoseltamab in combination with two different proteasome inhibitors – carfilzomib or ...

Bayer A.G. (OTCPK:BAYZF) (OTCPK:BAYRY) said that an advisory panel of the European Medicines Agency (EMA), endorsed the label ...

After a bumpy ride, the ride-hailing app is back in the good graces of investors. Plus: OpenAI, Google, Apple, Target, ...

Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced ...

Regeneron Pharmaceuticals has announced plans to acquire the genetic testing company 23andMe for $256 million, with a clear ...